Back to Trials
NCT07445074NARecruiting

AI-Based Mobile Intervention on Medication Non-Adherence and Transition

University of Central Florida

Start Date

5/1/2026

Completion Date

12/1/2026

Summary

This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA. Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.

Eligibility Criteria

Age Range: 14 years to 24 years

Inclusion Criteria: * Diagnosed with epilepsy * Currently prescribed anti-seizure medicine (ASMs) * Identified as part of an underserved population, defined as meeting at least one of the following: member of a racial or ethnic group historically underrepresented in research or healthcare or low-income status (e.g., eligible for public assistance or government-subsidized health coverage) * Are between 14-17 years old and able to provide assent, with a parent or LAR present to receive app notifications throughout the study * Are between 18-24 years old and able to provide informed consent * Able to read, speak, and write in English * Resides in Florida * Receive outpatient medical services Exclusion Criteria: * They do not own a mobile device with internet access. * They have a history of severe intellectual disability. * They are unable to operate a mobile device (keyboard or touchscreen). * Reside in an in-patient setting. * Adults unable to consent. * Pregnant women (excluded because pregnancy is not relevant to the study focus). * Prisoners.

Interventions

OTHER

Medilepsy® Chatbot AI-Enhanced

OTHER

Medilepsy® Chatbot Standard

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

EpilepsySeizure

Locations

Orlando Health Arnold Palmer Hospital

Orlando, Florida 32806

United States

Orlando Health Orlando Regional Medical Center

Orlando, Florida 32806

United States